CN Stock MarketDetailed Quotes

688073 Bide Pharmatech

Watchlist
  • 33.43
  • +1.10+3.40%
Market Closed Apr 26 15:00 CST
3.04BMarket Cap30.78P/E (TTM)

About Bide Pharmatech Company

The company is a high-tech enterprise focusing on the front end of the new drug research and development industry chain, relying on core businesses such as R&D, design, production and sales of pharmaceutical molecular blocks to provide new drug R&D institutions with novel and unique structures, diverse functions, and a rich variety of pharmaceutical molecular components and scientific reagents. The company is an enterprise that provides professional and efficient drug molecular blocks and scientific reagent products and services for new drug research and development institutions. The company's main products include: (1) pharmaceutical molecular blocks, which can be subdivided into heterocyclic compounds, benzene compounds, and aliphatic compounds; (2) scientific reagents: reagents that do not directly participate in the construction of compounds, but are indispensable in the development of new drugs, and can be subdivided into active small molecule compounds, catalysts, and ligands. Corporate honors: Shanghai “Specialized, Special and New” Small and Medium Enterprises in 2020, National Specialized, Special and New “Little Giant” Enterprises in 2021, etc. “Little Giant of Science and Technology in Shanghai” in 2021, “Shanghai Enterprise Technology Center” in 2023, etc.

Company Profile

Short Name-A毕得医药科技股份
Company NameBide Pharmatech Co., Ltd.
Listing DateOct 11, 2022
Issue Price88.00
Shares Offered16.23M share(s)
FoundedApr 27, 2007
Chairmanlan dai
Legal Representativelan dai
CEOlan dai
Secretarytao li
Employees846
ProvinceShang Hai Shi
Phone021-61601560
Office Address6th Floor, Building 3, No. 999 Xiangyin Road, Yangpu District, Shanghai
Zip Code200433
Registered AddressRoom 101, Block A, Building 11, No. 128, Xiangyin Road, Yangpu District, Shanghai
Fax021-61629029
Emailir@bidepharmatech.com
Business License91310110660715642B
BusinessThe company is a high-tech enterprise focusing on the front end of the new drug R&D industry chain, relying on core business such as R&D, design, production and sales of pharmaceutical molecular blocks, which can provide novel drug R&D institutions with novel structures and diverse functions, such as pharmaceutical molecular blocks and scientific reagents.

Company Executives

  • Name
  • Position
  • Salary
  • lan dai
  • directors
  • --
  • chao wang
  • directors,Deputy General Manager,Core technical personnel
  • 928.00K
  • zhichang liu
  • Independent directors
  • 19.40K
  • hong meng
  • Independent directors
  • 19.40K
  • yongping tao
  • Independent directors
  • 19.40K
  • xiaohu yu
  • Securities affairs representative
  • --
  • jiangbo wan
  • auditors
  • 712.60K
  • ronghao li
  • auditors,Core technical personnel
  • 549.90K
  • dieqing lv
  • Core technical personnel
  • 453.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg